{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"0","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"}],"units":"Participants"}],"description":"Count endpoint: Number of days subject spent in the ICU in the last 30 days of life","dispersionType":"Full Range","groups":[{"description":"Patients with aggressive hematologic malignancies who are hospice eligible, not pursuing further cancer directed therapy, and whose primary hematologist is planning to initiate a conversation regarding transition to hospice will be eligible for enrollment.\n\nTransfusion support: Patients will be offered symptom-driven transfusion support in addition to standard hospice care","id":"OG000","title":"Intervention Arm"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Last 30 days of life.","title":"Number of Days in the ICU in the Last 30 Days of Life","type":"SECONDARY","unitOfMeasure":"days"}